TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
复制标题
根据相似但不同的监管概况的定义,TCF11 比其原型 Nrf1α 具有更强大的肿瘤抑制作用,与 Nrf2 存在显着差异
DOI:
10.3389/fonc.2021.707032
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Zhang Y
中科院分区:
文献类型:
--
作者:
Wang M;Ren Y;Hu S;Liu K;Qiu L;Zhang Y
Nrf1 and Nrf2, as two principal CNC-bZIP transcription factors, regulate similar but different targets involved in a variety of biological functions for maintaining cell homeostasis and organ integrity. Of note, the unique topobiological behavior of Nrf1 makes its functions more complicated than Nrf2, because it is allowed for alternatively transcribing and selectively splicing to yield multiple isoforms (e.g., TCF11, Nrf1α). In order to gain a better understanding of their similarities and differences in distinct regulatory profiles, all four distinct cell models for stably expressing TCF11, TCF11ΔN, Nrf1α or Nrf2 have been herein established by an Flp-In™ T-REx™-293 system and then identified by transcriptomic sequencing. Further analysis revealed that Nrf1α and TCF11 have similar yet different regulatory profiles, although both contribute basically to positive regulation of their co-targets, which are disparate from those regulated by Nrf2. Such disparity in those gene regulations by Nrf1 and Nrf2 was further corroborated by scrutinizing comprehensive functional annotation of their specific and/or common target genes. Conversely, the mutant TCF11ΔN, resulting from a deletion of the N-terminal amino acids 2–156 from TCF11, resembles Nrf2 with the largely consistent structure and function. Interestingly, our further experimental evidence demonstrates that TCF11 acts as a potent tumor-repressor relative to Nrf1α, albeit both isoforms possess a congruous capability to prevent malignant growth of tumor and upregulate those genes critical for improving the survival of patients with hepatocellular carcinoma.
登录
查看更多内容
DOI:
10.3390/antiox9101025
发表时间:
2020-10-21
期刊:
Antioxidants (Basel, Switzerland)
影响因子:
--
作者:
Ibrahim L;Mesgarzadeh J;Xu I;Powers ET;Wiseman RL;Bollong MJ
通讯作者:
Bollong MJ
影响因子:
3.8
作者:
Anaya, Jordan
通讯作者:
Anaya, Jordan
影响因子:
2.4
作者:
Berginc, Katja;Kristl, Albin
通讯作者:
Kristl, Albin
影响因子:
5.3
作者:
Chen, LY;Kwong, M;Chan, JY
通讯作者:
Chan, JY
DOI:
10.1111/febs.12350
发表时间:
2013-08
期刊:
The FEBS journal
影响因子:
--
作者:
Lee CS;Ho DV;Chan JY
通讯作者:
Chan JY